Canada markets open in 3 hours 42 minutes

L'Oréal S.A. (LRLCY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
83.24-0.64 (-0.76%)
At close: 03:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close83.88
Open84.53
Bid0.00 x 0
Ask0.00 x 0
Day's Range82.68 - 84.68
52 Week Range70.12 - 97.48
Volume111,228
Avg. Volume94,209
Market Cap225.186B
Beta (5Y Monthly)0.53
PE Ratio (TTM)50.44
EPS (TTM)1.65
Earnings DateN/A
Forward Dividend & Yield0.97 (1.16%)
Ex-Dividend DateApr. 23, 2021
1y Target Est102.00
  • Reuters

    UPDATE 1-Alphabet's unprofitable Verily unit in skin-care deal with L'Oreal

    Alphabet Inc's money-losing health tech arm Verily on Thursday announced a new tie-up in its search for sustainable revenue, saying it would study skin health and explore new products with cosmetics maker L'Oreal SA . The company declined to disclose terms of what it called a "strategic, multi-year partnership and research collaboration" with L'Oreal. Executives who have left Verily have criticized it for signing flashy, one-off research collaborations with pharmaceutical companies instead of focusing more attention on landing recurring subscribers to its software for clinical research and disease management.

  • Reuters

    Alphabet's unprofitable Verily unit in skin-care deal with L'Oreal

    (Reuters) -Alphabet Inc's money-losing health tech arm Verily on Thursday announced a new tie-up in its search for sustainable revenue, saying it would study skin health and explore new products with cosmetics maker L'Oreal SA. The company declined to disclose terms of what it called a "strategic, multi-year partnership and research collaboration" with L'Oreal. Executives who have left Verily have criticized it for signing flashy, one-off research collaborations with pharmaceutical companies instead of focusing more attention on landing recurring subscribers to its software for clinical research and disease management.

  • GlobeNewswire

    L'Oréal and Verily announce first-of-its-kind strategic partnership to advance precision skin health

    PHOTO_L'ORÉAL_BIOMETRIC FACIAL RECOGNITION, 3D SCANNING TECHNOLOGY COPYRIGHT L'ORÉAL PHOTO_L'ORÉAL_SMART MIRROR CONCEPT COPYRIGHT METAMORWORKS ISTOCK NEWS RELEASE L’ORÉAL AND VERILY ANNOUNCE FIRST-OF-ITS-KIND STRATEGIC PARTNERSHIP TO ADVANCE PRECISION SKIN HEALTH Clichy, January 20, 2022 - L'Oréal, the world leader in beauty, and Verily, an Alphabet precision health company, announced today a strategic partnership, exclusive in beauty, to advance skin health. The first-of-its-kind partnership in